THBS1 and cancer: Proclarix (Proteomedix) combines tPSA and fPSA with cancer-related glycoproteins thrombospondin-1 (THBS1) and cathepsin D (CTSD) as well as age to calculate a patient’s probability of having clinically significant PC on biopsy [27].